Document Type
Original Article
Abstract
Introduction: SARS-CoV-2 infection has led to the development of a novel clinical entity known as post-COVID syndrome. Post-COVID syndrome is characterized by indicators that last more time than three weeks after a diagnosis of COVID-19 has been made. It occurs between ten percent and thirty-five percent of the time, but in individuals who have been hospitalized before, the frequency can be as high as 85 percent. Aim and objectives; Long term evaluation of Egyption patietns for post-COVID syndrome such as insomnia, fatigue, dizziness, palpitation, dyspnea, chest pain, and depression. Subjects and methods: This was cross sectional trial, was performed on 200 cases who already had corona virus, cured, and follow long term manifestations occurred to them. Patients were followed up for six months. All patients were hospitalized and diagnosed clinically by history and examination, laboratory by all COVID lab tests as CBC, CRP, ferritin and D-dimer, and radiologically by chest CT GGO appearance PCR. Patients who haven’t been diagnosed with the disease were excluded. Result: There were statistically significant (p-value = 0.029) decreased O2 saturation in patients with insomnia, chest pain(p-value = 0.016). Also, there were highly statistically significant (p-value < 0.001) decreased O2 saturation in patients with cough.There was statistically significant (p-value = 0.009) enlarged period of hospitalization in cases with cough (10.4 ± 4.5 days) when compared with patients without cough (8.8 ± 4.2 days). Conclusion: In conclusion, individuals with COVID-19 need to be followed closely for a very long time, even after they have fully recovered. Most medical centers can't keep up with patient demand during the current COVID-19 outbreak. Therefore, it can be difficult to schedule follow-up visits for patients. However, constant surveillance is required for a sizable portion of the post-COVID population. For post-COVID-19, we need to pay extra care to patients who have respiratory distress, are lethargic, or have had their disease for a long time.
Keywords
Post-COVID syndrome; anti-Sars-Cov-2 antibodies; Long COVID; Primary Health Care.
Subject Area
Chest
How to Cite This Article
Asmar, Abo Bakr Helal El; Halema, Khaled Mohammed Ibrahim; and Hammad, Alaa Adel Ibrahim
(2023)
"Post Covid Syndrome,"
Al-Azhar International Medical Journal: Vol. 4:
Iss.
12, Article 33.
DOI: https://doi.org/10.58675/2682-339X.2169
